Table 2.
Outcomes of Different Strategies in STEMI Patients Transferred to a Different Facility After Receiving Fibrinolytic Therapy
| Variable | Overall | Medical Therapy Alone | CA Without Revascularization | CA With Revascularization | P Value |
|---|---|---|---|---|---|
| Overall, n (%) | 18 814 (100.0) | 853 (4.5) | 2573 (13.7) | 15 388 (81.8) | |
| Primary outcome, % | |||||
| In‐hospital mortality | 3.5 | 20.0 | 6.6 | 2.1 | <0.001 |
| Secondary outcomes, % | |||||
| GI bleed | 0.4 | 1.1 | 0.4 | 0.4 | 0.011 |
| Bleeding requiring transfusion | 0.4 | 0.6 | 0.4 | 0.4 | 0.769 |
| ICH | 1 | 8.5 | 1.1 | 0.6 | <0.001 |
| LOS, d, median (IQR) | 3.0 (2.0–4.0) | 3.0 (2.0–6.0) | 3.0 (2.0–4.0) | 3.0 (2.0–4.0) | 0.323 |
| Adjusted cost, $, median (IQR) | 17 479 (12 912 –24 619) | 7701 (3936–14 001) | 10 892 (7868–15 461) | 18 773 (14 516–26 124) | <0.001 |
Abbreviations: CA, coronary angiography; GI, gastrointestinal; ICH, intracranial hemorrhage; IQR, interquartile range; LOS, length of stay; STEMI, ST‐segment elevation myocardial infarction.